Cardiac Repair With a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart.

Zhang, Yuan and Sivakumaran, Priyadharshini and Newcomb, Andrew E and Hernandez, Damián and Harris, Nicole and Khanabdali, Ramin and Liu, Guei-Sheung and Kelly, Darren J and Pébay, Alice and Hewitt, Alex W and Boyle, Andrew and Harvey, Richard P and Morrison, Wayne A and Elliott, David A and Dusting, Gregory J and Lim, Shiang Y (2015) Cardiac Repair With a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart. Stem Cells, 33 (10). pp.3100-13. ISSN 1549-4918 (OA)

Full text not available from this repository.
Link to published document: http://dx.doi.org/10.1002/stem.2101

Abstract

Cardiac resident stem cells (CRSCs) hold much promise to treat heart disease but this remains a controversial field. Here, we describe a novel population of CRSCs, which are positive for W8B2 antigen and were obtained from adult human atrial appendages. W8B2(+) CRSCs exhibit a spindle-shaped morphology, are clonogenic and capable of self-renewal. W8B2(+) CRSCs show high expression of mesenchymal but not hematopoietic nor endothelial markers. W8B2(+) CRSCs expressed GATA4, HAND2, and TBX5, but not C-KIT, SCA-1, NKX2.5, PDGFRα, ISL1, or WT1. W8B2(+) CRSCs can differentiate into cardiovascular lineages and secrete a range of cytokines implicated in angiogenesis, chemotaxis, inflammation, extracellular matrix remodeling, cell growth, and survival. In vitro, conditioned medium collected from W8B2(+) CRSCs displayed prosurvival, proangiogenic, and promigratory effects on endothelial cells, superior to that of other adult stem cells tested, and additionally promoted survival and proliferation of neonatal rat cardiomyocytes. Intramyocardial transplantation of human W8B2(+) CRSCs into immunocompromised rats 1 week after myocardial infarction markedly improved cardiac function (∼40% improvement in ejection fraction) and reduced fibrotic scar tissue 4 weeks after infarction. Hearts treated with W8B2(+) CRSCs showed less adverse remodeling of the left ventricle, a greater number of proliferating cardiomyocytes (Ki67(+) cTnT(+) cells) in the remote region, higher myocardial vascular density, and greater infiltration of CD163(+) cells (a marker for M2 macrophages) into the border zone and scar regions. In summary, W8B2(+) CRSCs are distinct from currently known CRSCs found in human hearts, and as such may be an ideal cell source to repair myocardial damage after infarction.
(NHMRC grants 1024817, 373705, and 573732), ARC Special Initiative in Stem Cell Science (SR110001002) and Foundation Leducq 13 CVD 01).

Item Type: Article
Additional Information: This article is available for free from the publisher's website (click on link)
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 22 Jan 2016 00:40
Last Modified: 17 Jan 2018 08:41
URI: https://eprints.victorchang.edu.au/id/eprint/225

Actions (login required)

View Item View Item